#76 - Cybin CEO: Doug Drysdale on The Future of Psychedelic Treatments

In this episode, we chat with , CEO of Cybin.  Cybin, is a life sciences company advancing mushroom based psychedelic pharmaceuticals and non-psychedelic nutraceutical products as potential therapies for psychiatric and neurological conditions....


Share this podcast

Continue Listening


Similar Podcasts